Observational studyScientific reports2025

The impact of androgen receptor pathway inhibitors as starting treatment in metastatic castration-sensitive prostate cancer on patient outcomes (OASIS Japan).

Masaki Shiota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.